WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH
Balance Sheet
Fiscal Year Start:
Jul 1
Assets in 2024 (Year End)
$903,412,304
Investments
81%
Property, Plant, & Equipment (net)
9%
Receivables (Non-Related)
5%
Cash & Equivalents
4%
Other Assets
1%
Prepaid Expenses
<1%
Related-Party Receivables
<1%
Inventories
0%
Liabilities in 2024 (Year End)
$140,485,697
Notes Payable / Debt (Non-Related)
76%
Payables & Accruals
11%
Other Liabilities
9%
Deferred Revenue
4%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$20,327,217
$33,483,027
+65%
Receivables (Non-Related)
$29,186,045
$41,076,637
+41%
Related-Party Receivables
$1,200,000
$1,050,000
-12%
Inventories
$0
$0
-
Prepaid Expenses
$1,945,967
$1,686,155
-13%
Investments
$698,368,142
$734,449,794
+5%
Property, Plant, & Equipment (net)
$79,848,962
$79,166,947
-1%
Other Assets
$11,540,751
$12,499,744
+8%
Total Assets
$842,417,084
$903,412,304
+7%
Liabilities
2023
2024
Change
Payables & Accruals
$9,948,514
$15,845,366
+59%
Grants Payable
$0
$0
-
Deferred Revenue
$5,787,909
$5,260,152
-9%
Tax-Exempt Bond Liabilities
$0
$0
-
Custodial & Escrow Liabilities
$0
$0
-
Notes Payable / Debt (Non-Related)
$106,702,031
$106,767,168
+0%
Related-Party Payables
$0
$0
-
Other Liabilities
$11,091,031
$12,613,011
+14%
Total Liabilities
$133,529,485
$140,485,697
+5%
Net assets
2023
2024
Change
Restricted Net Assets
$57,393,417
$65,039,317
+13%
Unrestricted Net Assets
$651,494,182
$697,887,290
+7%
Net assets
2023
2024
Change
Net assets
+$708,887,599
+$762,926,607
+8%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)